Apr 11, 2022
1:25
For every 25 shares held, investors received 1. The price per share adjusted from $0.27 to $6.75.
The split itself did not change the total investment value.
Rapid Therapeutic Science Laboratories, Inc. (OTC:RTSL) operates in the Pharmaceuticals: other industry.
Rapid Therapeutic Science Laboratories, Inc. company overviewRapid Therapeutic Science Laboratories, Inc.'s most recent stock split was on April 11, 2022. It was a 1-for-25 reverse split, so shareholders received 1 share for every 25 they held.
Rapid Therapeutic Science Laboratories, Inc. (OTC:RTSL) has split its stock 2 times: a 1-for-25 reverse split on March 31, 2022 and a 1-for-25 reverse split on April 11, 2022.
Rapid Therapeutic Science Laboratories, Inc. has split its stock 2 times. This history records 2 reverse splits between March 31, 2022 and April 11, 2022.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Rapid Therapeutic Science Laboratories, Inc.'s 1-for-25 reverse split on April 11, 2022, every 25 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Rapid Therapeutic Science Laboratories, Inc. has not announced a new split in our records. Its most recent split was on April 11, 2022, 4 years ago. Companies announce splits in advance, and any new OTC:RTSL split will appear on this page.